Skip to main content

Advertisement

SpringerLink
Log in

Serum BDNF, TNF-α and IL-1β levels in dementia patients

Comparison between Alzheimer’s disease and vascular dementia

  • ORIGINAL PAPER
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

An Erratum to this article was published on 13 October 2006

Abstract

Neurotrophins such as the brain-derived neurotrophic factor (BDNF) are reportedly related to the pathogenesis of Alzheimer’s disease (AD). Several studies have revealed an alteration in BDNF expression in the postmortem brains of AD patients. BDNF has great potential as a therapeutic agent because of its ability to cross the blood–brain barrier and due to its wide in vivo distribution. However, little is known about in vivo BDNF in dementia patients. Moreover, the immunological function of neurotrophins such as BDNF has received great interest. Therefore, we investigated the serum levels of BDNF and cytokines such as TNF-α and IL-1β in dementia patients by the enzyme-linked immunosorbent assay (ELISA). The following subjects were included in this study: 60 AD patients, 60 vascular dementia (VaD) patients and 33 healthy controls. AD and VaD patients were matched for age, gender and severity of dementia. Serum BDNF levels in AD patients were significantly lower than those in VaD patients and controls. TNF-α and IL-1β levels showed no significant difference among the three groups. In the dementia groups, neither the TNF-α nor the IL-1β levels correlated with the BDNF levels. Our results suggest that BDNF may play a pathological role in some cases of AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Whitehouse P, Price D, Stuble R, Clarke A, Delong M (1982) Alzheimer’s disease and senile dementia; loss of neurones in the basal forebrain. Science 215:1237–1239

    Article  PubMed  CAS  Google Scholar 

  2. Coyle JT, Price DL, Delong MR (1983) Alzheimer’s disease: a disorder of cortical cholinergic innervation. Science 219:1184–1190

    Article  PubMed  CAS  Google Scholar 

  3. Alderson RF, ALterman AL, Barde YA, Lindsay RM (1990) Brain derived neurotrophic factor increases survival and defferented functions of rat septal cholinergic neurons in culture. Neuron 5:297–306

    Article  PubMed  CAS  Google Scholar 

  4. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic neurone function in the adult and aged CNS. Trends Neurosci 17:486–490

    Article  PubMed  CAS  Google Scholar 

  5. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood–brain barrier. Neuropharmacology 37:1553–1561

    Article  PubMed  CAS  Google Scholar 

  6. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M (2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer’s disease. Brain Res Mol Brain Res 76:347–354

    Article  PubMed  CAS  Google Scholar 

  7. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M (1997) Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res Mol Brain Res 49:71–81

    Article  PubMed  CAS  Google Scholar 

  8. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron 7:695–702

    Article  PubMed  CAS  Google Scholar 

  9. Fujimura H, Altar CA, Chen R, Nakamura T, Nakahashi T, Kambayashi J (2002) Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 87:728–734

    PubMed  CAS  Google Scholar 

  10. Donovan MJ, Miranda RC, Kraemer R, McCafferey TA, Tseearollo L, Mahadeo D (1995) Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regul Exp Res Inj 147:309–324

    CAS  Google Scholar 

  11. Nakahashi T, Fujimura H, Altar CA, Li J, Kambayashi J, Tandon NN (2000) Vascular endothelial cells synthesize and secret brain-derived neurotrophic factor. FEBS Lett 470:113–117

    Article  PubMed  CAS  Google Scholar 

  12. Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328:261–264

    Article  PubMed  CAS  Google Scholar 

  13. Ferrer I, Marin C, Rey MJ (1999) BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58:729–739

    Article  PubMed  CAS  Google Scholar 

  14. Mufson EJ, Kroin JS, Sender TJ, Sobreviela T (1999) Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative disease. Prog Neurobiol 57:451–484

    Article  PubMed  CAS  Google Scholar 

  15. Miyake K, Yamamoto W, Tadokoro M (2002) Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res 935:24–31

    Article  PubMed  CAS  Google Scholar 

  16. Kokaia Z, Nawa H, Uchino H (1996) Regional brain-derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat. Brain Res Mol Brain Res 38:139–144

    Article  PubMed  CAS  Google Scholar 

  17. Lindvall O, Ernfors P, Bengzon J (1992) Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 89:648–652

    Article  PubMed  CAS  Google Scholar 

  18. Lee J, Fukumoto H, Orne J, Klucken J, Raju S, Vanderburg CR, Irizarry MC, Hyman BT, Ingelsson M (2005) Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 194:91–96

    Article  PubMed  CAS  Google Scholar 

  19. Tarkowski E, Blennow K, Wallin A, Tarkowski A (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J Clin Immunol 19:223–230

    Article  PubMed  CAS  Google Scholar 

  20. Alvarez XA, Franco A, Fernandez NL, Cacabelos R (1996) Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease. Mol Chem Neuropathol 29:237–252

    Article  PubMed  CAS  Google Scholar 

  21. Toyooka K, Asama K, Watanabe Y (2002) Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 110:249–257

    Article  PubMed  CAS  Google Scholar 

  22. Gobbo OL, O’Mara SM (2004) Post-tretment,but not pre-treatment, with the selective cyclooxygenase-2inhibitor celecoxob markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience 125:317–327

    Article  PubMed  CAS  Google Scholar 

  23. Shimizu E, Hashimoto K, Okamura K, Koike K, Komatsu N, Kumakiri C, Nakazoto M, Watanabe H, Shinoda N, Okada K, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70–75

    Article  PubMed  CAS  Google Scholar 

  24. Heun R, Kolsch H, Jessen F (2005) Risk factors and early signs of Alzheimer’s disease in a family study sample risk of AD. Eur Arch Psychiatry Clin Neurosci 20

  25. Hampel H, Halinger A, Scheloske M, Pedberg F, Fischer P, Unger J, Teipel SJ, Neumann M, Roseenberg C, Osida R, Hulette C, Pongratz D, Ewers M, Kretzschmar HA, Moller HJ (2005) Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer’s disease brain. Eur Arch Psychiatry Clin Neurosci 255:269–278

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuropsychiatry, Osaka Medical College, Daigakumachi 2-7, Takatsuki, Osaka, Japan

    Chie Yasutake & Hiroshi Yoneda

  2. Hannan Hospital, Hattaminaminocho 277, Sakai, Osaka, Japan

    Kenji Kuroda

  3. Shinabuyama Hospital, Nasahara 4-10-1, Takatsuki, Osaka, Japan

    Toshio Yanagawa & Takehiko Okamura

Authors
  1. Chie Yasutake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenji Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshio Yanagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takehiko Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Yoneda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chie Yasutake.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00406-006-0702-2.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yasutake, C., Kuroda, K., Yanagawa, T. et al. Serum BDNF, TNF-α and IL-1β levels in dementia patients. Eur Arch Psychiatry Clin Neurosci 256, 402–406 (2006). https://doi.org/10.1007/s00406-006-0652-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-006-0652-8

Keywords

Search

Navigation